These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2999257)
1. New observations regarding killing of fibroblasts infected with herpes simplex virus: cooperation between elutable factor and peripheral mononuclear cells. el Daher N; Betts RF J Infect Dis; 1985 Dec; 152(6):1197-205. PubMed ID: 2999257 [TBL] [Abstract][Full Text] [Related]
2. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji. Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183 [TBL] [Abstract][Full Text] [Related]
3. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. Leibson PJ; Hunter-Laszlo M; Douvas GS; Hayward AR J Clin Immunol; 1986 May; 6(3):216-24. PubMed ID: 3013922 [TBL] [Abstract][Full Text] [Related]
4. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Ching C; Lopez C Infect Immun; 1979 Oct; 26(1):49-56. PubMed ID: 227799 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135 [TBL] [Abstract][Full Text] [Related]
6. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA; Marlin SD; Schwartz SA; Glorioso JC J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157 [TBL] [Abstract][Full Text] [Related]
7. Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells. Kohl S; Moore CM Immunology; 1983 Jan; 48(1):187-93. PubMed ID: 6848451 [TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102 [TBL] [Abstract][Full Text] [Related]
10. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells. Howell DM; Fitzgerald-Bocarsly P Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403 [TBL] [Abstract][Full Text] [Related]
13. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. Colmenares C; Lopez C J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891 [TBL] [Abstract][Full Text] [Related]
14. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. Fitzgerald PA; Mendelsohn M; Lopez C J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cytotoxicity and antibody-dependent cell cytotoxicity to herpes simplex virus-infected target cells in murine pregnancy. Loftin KC; Gonik B; Kumaran P Am J Reprod Immunol Microbiol; 1988 Jun; 17(2):53-6. PubMed ID: 2847568 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts. Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells. López-Guerrero JA; Alarcón B; Fresno M J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762 [TBL] [Abstract][Full Text] [Related]
18. Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells. Kohl S; Drath DB; Loo LS Infect Immun; 1982 Dec; 38(3):1231-41. PubMed ID: 6295943 [TBL] [Abstract][Full Text] [Related]
19. The effect of route of delivery on neonatal natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Frazier JP; Kohl S; Pickering LK; Loo LS Pediatr Res; 1982 Jul; 16(7):558-60. PubMed ID: 6287398 [TBL] [Abstract][Full Text] [Related]
20. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays. Møller-Larsen A J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]